Tap to start →
Photo: Vitaly Gariev / Unsplash
1 / 3
Amycretin is an investigational Novo Nordisk molecule that activates both the GLP-1 and amylin receptors, studied as a weekly injection and as a daily pill.
2 / 3
CagriSema combines two molecules in one pen.
3 / 3
Amycretin is one of the main next-generation candidates, so you will see it in headlines well before it reaches pharmacies.
Amycretin is an investigational Novo Nordisk molecule that activates both the GLP-1 and amylin receptors, studied as a weekly injection and as a daily pill
Tap below for the full page. Not medical advice; talk to your clinician about your care.